PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
Laurie Herviou,
Alboukadel Kassambara,
Stéphanie Boireau,
Nicolas Robert,
Guilhem Requirand,
Carsten Müller-Tidow,
Laure Vincent,
Anja Seckinger,
Hartmut Goldschmidt,
Guillaume Cartron,
Dirk Hose,
Giacomo Cavalli,
Jerome Moreaux October 2018Publication
Clinical Epigenetics
